Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: A prospective study

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 11, 2012, Pages 3996-4003

  Joo, Ji Yong ^a   Park, Jae Yong ^a   Yoon, Yeo Hoon ^a   Choi, Bobae ^b   Kim, Jin Man ^b   Jo, Young Suk ^b   Shong, Minho ^b   Koo, Bon Seok ^a  

^a Chungnam National University   (South Korea)

^b Chungnam National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; IODINE 131; VALINE;

ABLATION THERAPY; ADULT; ALLELE; ARTICLE; BRAF GENE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; DIET SUPPLEMENTATION; FEMALE; FOLLOW UP; GENE; GENE MUTATION; HUMAN; HUMAN TISSUE; HYPOCALCEMIA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NEEDLE BIOPSY; OCCULT CENTRAL LYMPH NODE METASTASIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREDICTION; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; PYROSEQUENCING; REOPERATION; RISK FACTOR; SEQUENCE ANALYSIS; THYROID CARCINOMA; THYROIDECTOMY; TUMOR VOLUME; VAGOTOMY; VOCAL CORD PARALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA, PAPILLARY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS B-RAF; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 84868626681     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2444     Document Type: Article

References (46)

1. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167
2. Jemal A, Siegel R, Xu J, Ward E 2010 Cancer statistics, 2010. CA Cancer J Clin 60:277-300
3. Blansfield JA, Sack MJ, Kukora JS 2002 Recent experience with preoperative fine-needle aspiration biopsy of thyroid nodules in a community hospital. Arch Surg 137:818-821 (Pubitemid 34743173)
4. Castro MR, Gharib H 2003 Thyroid fine needle aspiration biopsy: progress, practice, and pitfalls. Endocr Pract 9:128-136
5. Ravetto C, Colombo L, Dottorini ME 2000 Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: a retrospective study in 37,895 patients. Cancer 90:357-363 (Pubitemid 32011847)
6. Layfield LJ, Cibas ES, Gharib H, Mandel SJ 2009 Thyroid aspiration cytology: current status. CA Cancer J Clin 59:99-110
7. Handkiewicz-Junak D, Czarniecka A, Jarzab B 2010 Molecular prognostic markers in papillary and follicular thyroid cancer: current status and future directions. Mol Cell Endocrinol 322:8-28
8. Pelizzo MR, Boschin IM, Barollo S, Pennelli G, Toniato A, Zambonin L, Vianello F, Piotto A, Ide EC, Pagetta C, Sorgato N, Torresan F, Girelli ME, Nacamulli D, Mantero F, Mian C 2011 BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience. Clin Chem Lab Med 49:325-329
9. Mathur A, Weng J, Moses W, Steinberg SM, Rahbari R, Rahabari R, Kitano M, Khanafshar E, Ljung BM, Duh QY, Clark OH, Kebebew E 2010 A prospective study evaluating the accuracy of using combined clinical factors and candidate diagnostic markers to refine the accuracy of thyroid fine needle aspiration biopsy. Surgery 148:1170-1177
10. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA 2003 High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63:1454-1457 (Pubitemid 36373628)
11. Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, Beller U, Westra WH, Ladenson PW, Sidransky D 2003 BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95:625-627 (Pubitemid 36553510)
12. Xing M 2005 BRAF mutation in thyroid cancer. Endocr Relat Cancer 12:245-262 (Pubitemid 40896444)
13. Espinosa AV, Porchia L, Ringel MD 2007 Targeting BRAF in thyroid cancer. Br J Cancer 96:16-20 (Pubitemid 46094633)
14. Xing M 2007 BRAF mutation in papillary thyroid cancer: pathologic role, molecular bases, and clinical implications. Endocr Rev 28:742-762 (Pubitemid 350294294)
15. Frasca F, Nucera C, Pellegriti G, Gangemi P, Attard M, Stella M, Loda M, Vella V, Giordano C, Trimarchi F, Mazzon E, Belfiore A, Vigneri R 2008 BRAF(V600E) mutation and the biology of papillary thyroid cancer. Endocr Relat Cancer 15:191-205 (Pubitemid 351449739)
16. Kebebew E, Weng J, Bauer J, Ranvier G, Clark OH, Duh QY, Shibru D, Bastian B, Griffin A 2007 The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg 246:466-471
17. Jo YS, Li S, Song JH, Kwon KH, Lee JC, Rha SY, Lee HJ, Sul JY, Kweon GR, Ro HK, Kim JM, Shong M 2006 Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer. J Clin Endocrinol Metab 91:3667-3670 (Pubitemid 44402153)
18. Kim J, Giuliano AE, Turner RR, Gaffney RE, Umetani N, Kitago M, Elashoff D, Hoon DS 2006 Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma. Ann Surg 244:799-804 (Pubitemid 44629955)
19. Mirallié E, Visset J, Sagan C, Hamy A, Le Bodic MF, Paineau J 1999 Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg 23:970-973; discussion 973-974
20. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y 2003 Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optical strategy for neck dissection. Ann Surg 237:399-407 (Pubitemid 38176456)
21. Pereira JA, Jimeno J, Miquel J, Iglesias M, Munné A, Sancho JJ, Sitges-Serra A 2005 Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 138:1095-1100, discussion 1100-1101
22. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428 (Pubitemid 24345593)
23. DeGroot LJ, Kaplan EL, McCormick M, Straus FH 1990 Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414-424
24. Tisell LE, Nilsson B, Mölne J, Hansson G, Fjälling M, Jansson S, Wingren U 1996 Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg 20:854-859 (Pubitemid 26281914)
25. Lundgren CI, Hall P, Dickman PW, Zedenius J 2006 Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106:524-531 (Pubitemid 43157614)
26. Henry JF, Gramatica L, Denizot A, Kvachenyuk A, Puccini M, Defechereux T 1998 Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg 383:167-169 (Pubitemid 28442533)
27. Lee YS, Kim SW, Kim SW, Kim SK, Kang HS, Lee ES, Chung KW 2007 Extent of routine central lymph node dissection with small papillary thyroid carcinoma. World J Surg 31:1954-1959 (Pubitemid 47415715)
28. Iyer NG, Shaha AR 2011 Central compartment dissection for well differentiated thyroid cancer ... and the band plays on. Curr Opin Otolaryngol Head Neck Surg 19:106-112
29. Antonelli A, Miccoli P, Ferdeghini M, Di Coscio G, Alberti B, Iacconi P, Baldi V, Fallahi P, Baschieri L 1995 Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. Thyroid 5:25-28
30. Jo YS, Huang S, Kim YJ, Lee IS, Kim SS, Kim JR, Oh T, Moon Y, An S, Ro HK, Kim JM, Shong M 2009 Diagnostic value of pyrosequencing for the BRAF V600E mutation in ultrasound-guided fine-needle aspiration biopsy samples of thyroid incidentalomas. Clin Endocrinol (Oxf) 70:139-144
31. Yeo MK, Liang ZL, Oh T, Moon Y, An S, Kim MK, Kim KS, Shong M, Kim JM, Jo YS 2011 Pyrosequencing cut-off value identifying BRAFV600E mutation in fine needle aspiration samples of thyroid nodules. Clin Endocrinol (Oxf) 75:555-560
32. Witt RL 2008 Initial surgical management of thyroid cancer. Surg Oncol Clin N Am 17:71-91, viii
33. Moley JF, Lairmore TC, Doherty GM, Brunt LM, DeBenedetti MK 1999 Preservation of the recurrent laryngeal nerves in thyroid and parathyroid reoperations. Surgery 126:673-677; discussion 677-679
34. Kim MK, Mandel SH, Baloch Z, Livolsi VA, Langer JE, Didonato L, Fish S, Weber RS 2004 Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 130:1214-1216 (Pubitemid 39371970)
35. Choi JS, Kim J, Kwak JY, Kim MJ, Chang HS, Kim EK 2009 Preoperative staging of papillary thyroid carcinoma: Comparison of ultrasound imaging and CT. AJR Am J Roentgenol 193:871-878
36. Roh JL, Park JY, Kim JM, Song CJ 2009 Use of preoperative ultrasonography as guidance for neck dissection in patients with papillary thyroid carcinoma. J Surg Oncol 99:28-31
37. Kouvaraki MA, Shapiro SE, Fornage BD, Edeiken-Monro BS, Sherman SI, Vassilopoulou-Sellin R, Lee JE, Evans DB 2003 Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 134:946-954
38. Bonnet S, Hartl D, Leboulleux S, Baudin E, Lumbroso JD, Al Ghuzlan A, Chami L, Schlumberger M, Travagli JP 2009 Prophylactic lymph node dissection for papillary thyroid cancer less than 2cm: implications for radioiodine treatment. J Clin Endocrinol Metab 94:1162-1167
39. Mercante G, Frasoldati A, Pedroni C, Formisano D, Renna L, Piana S, Gardini G, Valcavi R, Barbieri V 2009 Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 19:707-716
40. Xing M, Clark D, Guan H, Ji M, Dackiw A, Carson KA, Kim M, Tufaro A, Ladenson P, Zeiger M, Tufano R 2009 BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol 27:2977-2982
41. Goropoulos A, Karamoshos K, Christodoulou A, Ntitsias T, Paulou K, Samaras A, Xirou P, Efstratiou I 2004 Value of the cervical compartments in the surgical treatment of papillary thyroid carcinoma. World J Surg 28:1275-1281 (Pubitemid 40941292)
42. Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L 2006 Routine level six lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140:1000-1005; discussion 1005-1007
43. Gemsenjäger E, Perren A, Seifert B, Schüler G, Schweizer I, Heitz PU 2003 Lymph node surgery in papillary thyroid carcinoma. J Am Coll Surg 197:182-190 (Pubitemid 36927380)
44. Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
45. Tuttle RM, Ball DW, Byrd D, Dilawari RA, Doherty GM, Duh QY, Ehya H, Farrar WB, Haddad RI, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey JC, Olson Jr JA, Parks L, Ridge JA, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ 2010 Thyroid carcinoma. J Natl Compr Canc Netw 8:1228-1274
46. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P 2010 American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. Endocr Pract 16:468-475